Kimberly J. Legault
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Devastating neurologic consequences of localized scleroderma en coup de sabre of the scalp-2 case studies.
Journal: Journal of scleroderma and related disorders
Published: January 21, 2025
Characteristics of Patients With Adult-Onset Dermatomyositis at 2 Tertiary Care Centres in Ontario, Canada.
Journal: Journal of cutaneous medicine and surgery
Published: November 26, 2024
Prevalence and risk factors of interstitial lung disease in dermatomyositis: A retrospective study.
Journal: Journal of the American Academy of Dermatology
Published: March 13, 2024
2023 ACR/EULAR antiphospholipid syndrome classification criteria.
Journal: Annals of the rheumatic diseases
Published: June 21, 2023
Risk factors for malignancy in adult-onset dermatomyositis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 31, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 07, 2023
Paraneoplastic Polyarthritis in Hepatocellular Carcinoma Treated With Lenvatinib.
Journal: Hepatology (Baltimore, Md.)
Published: October 19, 2020
Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome.
Journal: Pilot and feasibility studies
Published: June 02, 2020
A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome.
Journal: Pilot and feasibility studies
Published: April 05, 2019
Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.
Journal: The Journal of rheumatology
Published: July 13, 2018
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome.
Journal: Journal of thrombosis and haemostasis : JTH
Published: April 16, 2018
Last Updated: 09/26/2026